Vera Therapeutics

Forecast & Rating14 analysts currently cover Vera Therapeutics, with about 92.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $77.50, about 130.2% upside from the current price of $33.67. Price targets range from $34.00 to $100.00 — a wide spread, showing clear disagreement over just how much Vera Therapeutics can rise. Historically, about 58.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Vera Therapeutics closely still see room for the stock to rise. Data as of Sep 15, 2026; for reference only and not investment advice.